Argitalpenak (11) JESUS MARIA DE FRUTOS BARAJA argitalpenak

2018

  1. Episcleral brachytherapy as an effective alternative in vasoproliferative tumors

    International Journal of Ophthalmology, Vol. 11, Núm. 12, pp. 2017-2020

  2. Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part I

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 4, pp. 337-346

  3. Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part II

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 4, pp. 347-359

  4. Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 2, pp. 123-131

2017

  1. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit

    American Journal of Ophthalmology, Vol. 180, pp. 39-45

2012

  1. Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma

    Eye, Vol. 26, Núm. 1, pp. 159-162

2001

  1. A tool for contour comparison in different image sets

    Physica Medica

  2. Assessment of different reconstruction methods in a brachytherapy treatment planning system

    Physica Medica

  3. Exit dose as a method to verify external radiotherapy treatments in vivo by TLD's

    Physica Medica

  4. Introduction to medical physics (Radiotherapy) for physics sciences students

    Physica Medica

  5. Use of general brachytherapy planning system with epiescleral plaques

    Physica Medica